Boot Camp 2015 3/5/15 Abstracting & Coding Boot Camp: Cancer - - PDF document

▶
boot camp 2015 3 5 15
SMART_READER_LITE
LIVE PREVIEW

Boot Camp 2015 3/5/15 Abstracting & Coding Boot Camp: Cancer - - PDF document

Nov 22, 2022 425 likes •558 views

Boot Camp 2015 3/5/15 Abstracting & Coding Boot Camp: Cancer Case Scenarios 2014-2015 NAACCR Webinar Series March 5, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you

slide-1
SLIDE 1

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 1

Abstracting & Coding Boot Camp: Cancer Case Scenarios

2014-2015 NAACCR Webinar Series March 5, 2015

Q&A

  • Please submit all questions concerning webinar

content through the Q&A panel. Reminder:

  • If you have participants watching this webinar

at your site, please collect their names and emails.

  • We will be distributing a Q&A document in about one week.

This document will fully answer questions asked during the webinar and will contain any corrections that we may discover after the webinar.

2

F ABUL OUS PRIZE S

3

slide-2
SLIDE 2

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 2

2015 DAT A COL L E CT ION CHANGE S

Things Are Changing…..AGAIN

2015 CHANGE S

  • NAACCR 2015 Implementation Guidelines and

Recommendations

  • Plan for implementation of NAACCR Standards for

Cancer Registries Volume II, Data Standards and Data Dictionary Version 15

  • http://www.naaccr.org/LinkClick.aspx?fileticket=iD

QUZb2CDPY%3d&tabid=161&mid=523

5

ST ANDARD SE T T E RS

  • Commission on Cancer (CoC)
  • Centers for Disease Control and Prevention

(CDC) National Program of Cancer Registries (NPCR)

  • National Cancer Institute (NCI) Surveillance,

Epidemiology, and End Results (SEER) Program

  • Canadian Council of Cancer Registries

(CCCR)

6

slide-3
SLIDE 3

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 3

NE W DAT A IT E MS

Ne w Surviva l Da ta Ite ms

Data Item Name Item# Surv-Date Active Followup 1782 Surv-Flag Active Followup 1783 Surv-Mos Active Followup 1784 Surv-Date Presumed Alive 1785 Surv-Flag Presumed Alive 1786 Surv-Mos Presumed Alive 1787 Surv-Date DX Recode 1788

7

CHANGE D DAT A IT E MS

  • Sex (Item #220)
  • Code 4 updated
  • Transsexual NOS
  • Code 5 added
  • Transsexual, natal male
  • Code 6 added
  • Transsexual, natal female

8

CHANGE D DAT A IT E MS

  • Country codes (Item #s 102, 254, 1832, 1847,

1944)

9

Country Old Code Ne w c ode

Yugoslavia XYG YUG Czechoslovakia XCG CSK Brunei BND BRN Slovakia SWK SVK Vanuatu VLT VUT

slide-4
SLIDE 4

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 4

HE MAT OPOIE T IC & L YMPHOID NE OPL ASM CODING MANUAL & DAT ABASE

  • Update released 1/14/15
  • Revision History for the Hematopoietic Project
  • http://seer.cancer.gov/tools/heme/update.html
  • Provides data collection rules for

hematopoietic and lymphoid neoplasms diagnosed 2010 and forward

  • Web-based version of database
  • Stand-alone version of database

10

HE MAT OPOIE T IC & L YMPHOID NE OPL ASM CODING MANUAL & DAT ABASE CHANGE S

  • Diagnostic confirmation
  • Code 1
  • Peripheral blood smear can be counted as a histologic

diagnoses for All hematopoietic histologies (9590/3-9992/3

  • r no /3)
  • CBC and WBC can be used for leukemias only (9800-9948)
  • Code 3
  • Genetics and/or immunophenotyping added to all

applicable diseases on database

11

HE MAT OPOIE T IC & L YMPHOID NE OPL ASM CODING MANUAL & DAT ABASE CHANGE S

  • Obsolete Hematopoietic Histologies
  • 24 histologies designated as obsolete in Heme

Database & Manual 1/1/2010

  • Conversion
  • Apply to histology, primary site, and grade
  • Based on rules in the Database and Manual
  • The Hematopoietic Conversion Documentation
  • Appendix B of NAACCR 2015 Implementation Guidelines

and Recommendations

12

slide-5
SLIDE 5

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 5

HE MAT OPOIE T IC & L YMPHOID NE OPL ASM CODING MANUAL & DAT ABASE CHANGE S

  • First Course of Treatment for Hematopoietic

Neoplasms

  • New section provides information on coding

treatment

  • M Instructions and Rules
  • Changes are minor and clarify
  • PH Instructions and Rules
  • Primary Site Coding Instructions
  • Histology Coding Instructions

13

HE MAT OPOIE T IC & L YMPHOID NE OPL ASM CODING MANUAL & DAT ABASE CHANGE S

  • Appendix F: Non-reportable terms
  • Deleted
  • Glossary
  • New feature
  • Terms underlined in hematopoietic entry and can be

clicked to see definition

14

ICD- O- 3

  • Guidelines for ICD-O-3 Update Implementation
  • http://www.naaccr.org/LinkClick.aspx?fileticket=u7

d3sB71t5w%3d&tabid=126&mid=466

15

slide-6
SLIDE 6

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 6

ICD- O- 3

  • 2015 Reportability and Recode Changes
  • Reportability and Behavior Change
  • Code carcinoid tumor NOS of appendix (C18.1) to 8240/3
  • Recode Changes

16

T e rm Pre - 2015 Code 2015 a nd L a te r Code

Enteroglucagonoma, NOS 8157/1 8152/1 Enteroglucagonoma, malignant 8157/3 8152/3

ICD- O- 3

  • New codes cannot be used for 2015 diagnoses

because they are not acceptable histologies for CS algorithms

  • Use ICD-O-3 Histology Code Crosswalk to code new

terms using current codes

  • Appendix A of NAACCR 2015 Implementation Guideline

17

ICD- O- 3

  • Online version of ICD-O-3 from International

Agency for Research on Cancer

  • http://codes.iarc.fr/
  • Use ICD-O-3 (2000) for solid tumors
  • Do not use ICD-O-3 (2011)
  • Use histology rules from Hematopoietic and Lymphoid

Neoplasm Coding Manual and Database

  • Refer to the NAACCR Guidelines for ICD-O-3 Update

Implementation for the list of ICD-O-3 code changes effective 1/1/2015

  • Use histology rules in MP/H Manual for solid tumors

18

slide-7
SLIDE 7

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 7

ST AGE COL L E CT ION RE QUIRE ME NT S

  • CoC 2015 Requirements
  • CS v02.05 required
  • Directly assigned AJCC TNM (clinical and

pathologic) required for class of case 10-22

19

ST AGE COL L E CT ION RE QUIRE ME NT S

  • CDC NPCR 2015 Requirements
  • CS v02.05 required
  • Directly assigned SEER Summary Stage 2000 required

by all facilities

  • Directly assigned AJCC TNM (clinical and

pathologic)

  • Required from CoC accredited hospitals
  • As available from non-CoC facilities and small providers

20

ST AGE COL L E CT ION RE QUIRE ME NT S

  • NCI SEER 2015 Requirements
  • CS v02.05 required
  • Directly assigned AJCC TNM (clinical and

pathologic)

  • Required from CoC accredited hospitals when available

21

slide-8
SLIDE 8

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 8

ST AGE COL L E CT ION RE QUIRE ME NT S

  • CCCR Requirements
  • CS v02.05 required until the end of 2016 diagnosis

year

  • Plan to implement collection of AJCC TNM stage with

expected release of AJCC Cancer Staging Manual, 8th Edition

22

OT HE R RE QUIRE ME NT S 2015

  • CDC NPCR
  • All treatment and associated dates for all cancers
  • NCI SEER
  • Treatment associated dates for all cancers

23

CHAL L E NGING ANAT OMY

Quiz 1

24

slide-9
SLIDE 9

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 9

DAT A IT E MS BE SIDE S SIT E MORPHOL OGY… T HE Y ARE IMPORT ANT !

Quiz 2

25

IDE NT IF YING & CODING PRIMARY SIT E & HIST OL OGY F OR COMPL ICAT E D CASE S

Quiz 3

26

ST AGING CONUNDRUMS

Quiz 4

27

slide-10
SLIDE 10

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 10

HE R2 T E ST ING

  • Recommendations for Human Epidermal Growth Factor

2 Testing in Breast Cancer

  • http://www.cap.org/apps/cap.Portal?_nfpb=true&cntvwrPtlt

_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&cnt vwrPtlt%7BactionForm.contentReference%7D=committees%2 Fimmunohistochemistry%2Fher2_index.html&_pageLabel=cnt vwr

  • ASCO–CAP HER2 Test Guideline Recommendations
  • Summary of Recommendations
  • http://www.cap.org/apps/cap.Portal?_nfpb=true&cntvwrP

tlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow& cntvwrPtlt%7BactionForm.contentReference%7D=committe es%2Fimmunohistochemistry%2Fher2_index.html&_pageLab el=cntvwr

28

2013 RE COMME NDAT ION

  • Report HER2 test result positive
  • IHC 3+ based on circumferential membrane staining

that is complete, intense

  • ISH positive based on:
  • Single-probe average HER2 copy number ≥6.0 signals/cell
  • Dual-probe HER2/CEP17 ratio ≥2.0; with an average HER2

copy number ≥4.0 signals/cell

  • Dual-probe HER2/CEP17 ratio ≥2.0; with an average HER2

copy number <4.0 signals/cell

  • Dual-probe HER2/CEP17 ratio < 2.0; with an average HER2

copy number ≥6.0 signals/cell

29

E XAMPL E

  • HER2 FISH test result: Ratio of 1.52; average

copy number 6.0 signals/cell; elevated HER2

  • What is the code for CS SSF10 (FISH Lab

Value)?

  • What is the code for CS SSF11(HER2: FISH Test

Interpretation)?

30

slide-11
SLIDE 11

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 11

T RE AT ME NT

Quiz 5

31

DO YOU KNOW YOUR ST ANDARD SE T T E RS?

Quiz 6

32

COMING UP…

  • Collecting Cancer Data: Stomach &

Esophagus

  • 4/2/15
  • Collecting Cancer Data: Larynx & Thyroid
  • 5/7/15

33

slide-12
SLIDE 12

Boot Camp 2015 3/5/15 NAACCR 2014-2015 Webinar Series 12

AND T HE WINNE RS ARE … ..

34

CE CE RT IF ICAT E QUIZ/ SURVE Y

  • Phrase
  • Link
  • http://www.surveygizmo.com/s3/2033273/Boot-Camp-2015

35